Key points are not available for this paper at this time.
What is already known about this topic?: With the expanding coverage of antiretroviral therapy (ART), life expectancy among people living with human immunodeficiency virus (HIV) has increased significantly. However, relevant research evidence in China remains very limited. What is added by this report?: From 2013 to 2023, China witnessed a remarkable improvement in life expectancy among HIV-infected patients receiving ART, with the disparity compared to the general population narrowing annually. What are the implications for public health practice?: Our findings recognize the remarkable progress made in ART implementation in China over the past decade, providing timely evidence for improving the health status of HIV population and addressing the emerging challenges of an aging HIV population.
Wei et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: